Surveying Drug Delivery Companies

 

The report profiles 83 of the largest companies in the drug-delivery field and some of the smaller companies sniping at their heels. It uses BMI’s expertise to provide a detailed overview into a selection of some of the key players in the drug-delivery field, with the latest product development and R&D news, financial data and competitive analysis as well as mergers and acquisitions intelligence.

The drug-delivery market is constantly changing and evolving, sparking increasing interest from investors and medical professionals as new technologies come to market. Understanding the competitive landscape for such a diverse market and insight into its growth is essential.

Surveying Drug Delivery Companies
Product Price
$1,830.00

The Report provides detailed analysis of 94 leading companies covering:

  • Company Overview
  • Key Competitors
  • Key Milestones
  • Agreements
  • Technologies/Products
  • R&D Milestones
  • Key Financial Data
  • Key Personnel

Surveying Drug Delivery Companies provides a unique examination of trends and advances in major drug-delivery areas, featuring:

  • Identification of key application areas
  • Appraisals of currently available products which utilise advanced delivery platforms.
  • Examination of new product developments from major specialist drug-delivery companies.
  • Allows ready comparison on different technologies within these companies' portfolios.

This up-to-date report features the latest industry developments and highlights how the importance of drug delivery in the healthcare industry is increasingly apparent and commercial.

The report can be used to:

  • Assess the strengths and weaknesses of competing products/technologies in the context of specific delivery sectors and development companies.
  • Identify and review licensing and collaborative partners.
  • Understand the merits and applications of the main approaches being researched.